Carbetocin versus oxytocin for the prevention of post-partum hemorrhage in caesarean sectio
Phase 4
Completed
- Conditions
- Pregnancy and ChildbirthThird stage of labour
- Registration Number
- ISRCTN69805695
- Lead Sponsor
- Beacon Pharmaceuticals Ltd (Bangladesh)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 64
Inclusion Criteria
Women with a single pregnancy undergoing cesarean delivery at term
Exclusion Criteria
1. Placenta praevia
2. Multiple gestations
3. Placental abruption
4. Hypertensive disorders in pregnancy
5. Preeclampsia
6. Cardiac, renal or liver diseases
7. Epilepsy
8. Women with history of hypersensitivity to carbetocin according to the Br National Formulary
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of carbetocin over oxytocin for the management of third stage of labor
- Secondary Outcome Measures
Name Time Method 1. The need for additional uterotonic within 24 hours of delivery after carbetocin or oxytocin administration <br>2. The amount of blood loss in 24 hours after delivery after carbetocin or oxytocin administration<br>3. The need for blood transfusion during the first 24 hours after delivery after carbetocin or oxytocin administration<br>4. The adverse effects of carbetocin and oxytocin after administration